Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy
Inflammopharmacology · 2024-06 · 32 (3) · 1999-2006
DOI: 10.1007/s10787-024-01467-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 20.04.2024. Verfasst von Shuting Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The First People' Hospital of Linping Dstrict, Zhejiang Province, Hangzhou, 311199, China. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Platelet Aggregation Inhibitors, Gastrointestinal Hemorrhage, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, The First People' Hospital of Linping Dstrict, Zhejiang Province, Hangzhou, 311199, China.
- Department of Gastroenterology, Xinchang People's Hospital, Zhejiang Province, Shaoxing, 312500, China. wangjiqfcu586534@163.com.
Zitieren
APA
Yang, S., & Shi, L. (2024). Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy. Inflammopharmacology, 32(3), 1999-2006. https://doi.org/10.1007/s10787-024-01467-2
Vancouver
Yang S, Shi L. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy. Inflammopharmacology. 2024;32(3):1999-2006. doi:10.1007/s10787-024-01467-2
BibTeX
@article{Yang2024,
author = {Yang, Shuting and Shi, Linni},
title = {Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy},
journal = {Inflammopharmacology},
year = {2024},
volume = {32},
number = {3},
pages = {1999--2006},
doi = {10.1007/s10787-024-01467-2}
}
EUVIMED